Andrew Atz to Child
This is a "connection" page, showing publications Andrew Atz has written about Child.
Connection Strength
1.631
-
Costs associated with acute kidney injury in critically Ill neonates with patent Ductus arteriosus: pediatric health information system?(PHIS) analysis. J Perinatol. 2022 Dec; 42(12):1669-1673.
Score: 0.096
-
Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure. J Am Heart Assoc. 2022 01 18; 11(2):e024095.
Score: 0.092
-
Remestemcel-L Therapy for COVID-19-Associated Multisystem Inflammatory Syndrome in Children. Pediatrics. 2021 05; 147(5).
Score: 0.086
-
Longitudinal Outcomes of Patients?With?Single Ventricle After?the?Fontan?Procedure. J Am Coll Cardiol. 2017 Jun 06; 69(22):2735-2744.
Score: 0.067
-
Effect of Sildenafil on Pressure-Volume Loop Measures of Ventricular Function in Fontan Patients. Pediatr Cardiol. 2016 Jan; 37(1):184-91.
Score: 0.059
-
Estimating equations for cardiopulmonary exercise testing variables in Fontan patients: derivation and validation using a multicenter cross-sectional database. Pediatr Cardiol. 2015 Feb; 36(2):393-401.
Score: 0.055
-
Effect of human leukocyte antigen-C and -DQ matching on pediatric heart transplant graft survival. J Heart Lung Transplant. 2014 Dec; 33(12):1282-7.
Score: 0.055
-
Cardiac performance and quality of life in patients who have undergone the Fontan procedure with and without prior superior cavopulmonary connection. Cardiol Young. 2013 Jun; 23(3):335-43.
Score: 0.048
-
Response to a single dose of sildenafil in single-ventricle patients: an echocardiographic evaluation. Pediatr Cardiol. 2013 Oct; 34(7):1739-42.
Score: 0.048
-
Late status of Fontan patients with persistent surgical fenestration. J Am Coll Cardiol. 2011 Jun 14; 57(24):2437-43.
Score: 0.044
-
Factors associated with serum brain natriuretic peptide levels after the Fontan procedure. Congenit Heart Dis. 2011 Jul-Aug; 6(4):313-21.
Score: 0.043
-
Comparison of Norwood shunt types: do the outcomes differ 6 years later? Ann Thorac Surg. 2010 Jul; 90(1):31-5.
Score: 0.041
-
Functional state of patients with heterotaxy syndrome following the Fontan operation. Cardiol Young. 2007 Sep; 17 Suppl 2:44-53.
Score: 0.034
-
Simplified pulmonary vasodilatory testing in the cardiac catheterization laboratory with nasal cannula nitric oxide. Pediatr Cardiol. 2006 Jan-Feb; 27(1):84-86.
Score: 0.030
-
Active vs Traditional Methods of Recruiting Children for a Clinical Trial in Rural Primary Care Clinics: A Cluster-Randomized Clinical Trial. JAMA Netw Open. 2022 11 01; 5(11):e2244040.
Score: 0.024
-
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age. N Engl J Med. 2022 05 26; 386(21):2011-2023.
Score: 0.023
-
Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity. CPT Pharmacometrics Syst Pharmacol. 2022 06; 11(6):778-791.
Score: 0.023
-
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination. Circulation. 2022 02; 145(5):345-356.
Score: 0.023
-
Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial. Pediatr Cardiol. 2021 Apr; 42(4):934-941.
Score: 0.022
-
Six-Year Neurodevelopmental Outcomes for Children With Single-Ventricle Physiology. Pediatrics. 2021 02; 147(2).
Score: 0.021
-
Recruitment, retention, and adherence in a clinical trial: The Pediatric Heart Network's Marfan Trial experience. Clin Trials. 2020 12; 17(6):684-695.
Score: 0.021
-
Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents. Clin Transl Sci. 2020 11; 13(6):1189-1198.
Score: 0.020
-
Longitudinal study of anthropometry in Fontan survivors: Pediatric Heart Network Fontan study. Am Heart J. 2020 06; 224:192-200.
Score: 0.020
-
The Bayley-III scale may underestimate neurodevelopmental disability after cardiac surgery in infants. Eur J Cardiothorac Surg. 2020 01 01; 57(1):63-71.
Score: 0.020
-
Variation in care for children undergoing the Fontan operation for hypoplastic left heart syndrome. Cardiol Young. 2019 Dec; 29(12):1510-1516.
Score: 0.020
-
Behavior and Quality of Life at 6 Years for Children With Hypoplastic Left Heart Syndrome. Pediatrics. 2019 11; 144(5).
Score: 0.020
-
Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents. J Clin Pharmacol. 2019 12; 59(12):1606-1619.
Score: 0.019
-
Creation of a Multicenter Pediatric Inpatient Data Repository Derived from Electronic Health Records. Appl Clin Inform. 2019 03; 10(2):307-315.
Score: 0.019
-
Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol. 1999 Mar; 33(3):813-9.
Score: 0.019
-
Heart failure after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial. J Heart Lung Transplant. 2018 07; 37(7):879-885.
Score: 0.017
-
Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank. J Am Heart Assoc. 2018 02 10; 7(4).
Score: 0.017
-
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children. Antimicrob Agents Chemother. 2018 01; 62(1).
Score: 0.017
-
Longer Ischemic Time is Associated with Increased Ventricular Stiffness as Measured by Pressure-Volume Loop Analysis in Pediatric Heart Transplant Recipients. Pediatr Cardiol. 2018 Feb; 39(2):324-328.
Score: 0.017
-
Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology. 1997 Oct; 87(4):988-90.
Score: 0.017
-
A preliminary comparison of two-dimensional speckle tracking echocardiography and pressure-volume loop analysis in patients with Fontan physiology: The role of ventricular morphology. Echocardiography. 2017 Sep; 34(9):1353-1359.
Score: 0.017
-
Effects of persistent Fontan fenestration patency on cardiopulmonary exercise testing variables. Congenit Heart Dis. 2017 Jul; 12(4):399-402.
Score: 0.017
-
Effect of Induction Therapy on Graft Survival in Primary Pediatric Heart Transplantation: A Propensity Score Analysis of the UNOS Database. Transplantation. 2017 06; 101(6):1228-1233.
Score: 0.017
-
Decline in ventricular function as a result of general anesthesia in pediatric heart transplant recipients. Pediatr Transplant. 2016 Dec; 20(8):1106-1110.
Score: 0.016
-
Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis. Am J Cardiol. 1996 Feb 01; 77(4):316-9.
Score: 0.015
-
Factors affecting Fontan length of stay: Results from the Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg. 2016 Mar; 151(3):669-675.e1.
Score: 0.015
-
Validation of a Simple Score to Determine Risk of Early Rejection After Pediatric Heart Transplantation. JACC Heart Fail. 2015 Sep; 3(9):670-6.
Score: 0.015
-
Improved Detection of Cardiac Allograft Vasculopathy: A Multi-Institutional Analysis of Functional Parameters in Pediatric Heart Transplant Recipients. J Am Coll Cardiol. 2015 Aug 04; 66(5):547-57.
Score: 0.015
-
Association Between Method of Cerebral Protection During Neonatal Aortic Arch Surgery and Attention Deficit/Hyperactivity Disorder. Ann Thorac Surg. 2015 Aug; 100(2):663-70.
Score: 0.015
-
Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots. Bioanalysis. 2015; 7(9):1137-49.
Score: 0.014
-
Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med. 2014 Nov 27; 371(22):2061-71.
Score: 0.014
-
Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study. J Heart Lung Transplant. 2015 Sep; 34(9):1163-8.
Score: 0.014
-
Association of human leukocyte antigen donor-recipient matching and pediatric heart transplant graft survival. Circ Heart Fail. 2014 Jul; 7(4):605-11.
Score: 0.013
-
The prevalence of attention-deficit/hyperactivity disorder following neonatal aortic arch repair. Cardiol Young. 2015 Apr; 25(4):663-9.
Score: 0.013
-
The relationship of patient medical and laboratory characteristics to changes in functional health status in children and adolescents after the Fontan procedure. Pediatr Cardiol. 2014 Apr; 35(4):632-40.
Score: 0.013
-
Functional health status in children and adolescents after Fontan: comparison of generic and disease-specific assessments. Cardiol Young. 2014 Jun; 24(3):469-77.
Score: 0.013
-
Factors impacting echocardiographic imaging after the Fontan procedure: a report from the pediatric heart network fontan cross-sectional study. Echocardiography. 2013 Oct; 30(9):1098-106.
Score: 0.013
-
Reduction in postoperative high-density lipoprotein cholesterol levels in children undergoing the Fontan operation. Pediatr Cardiol. 2012 Oct; 33(7):1154-9.
Score: 0.012
-
Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan completion: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. Am Heart J. 2011 Jul; 162(1):125-30.
Score: 0.011
-
Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome. Am Heart J. 2010 Dec; 160(6):1092-8, 1098.e1.
Score: 0.011
-
The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers. Pediatr Cardiol. 2010 Nov; 31(8):1219-28.
Score: 0.011
-
Partial and transitional atrioventricular septal defect outcomes. Ann Thorac Surg. 2010 Feb; 89(2):530-6.
Score: 0.010
-
Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure. Circulation. 2010 Jan 05; 121(1):34-42.
Score: 0.010
-
Innovation in congenital and paediatric cardiac critical care. Cardiol Young. 2009 Nov; 19 Suppl 2:85-9.
Score: 0.010
-
Parent- versus child-reported functional health status after the Fontan procedure. Pediatrics. 2009 Nov; 124(5):e942-9.
Score: 0.010
-
Functional state following the Fontan procedure. Cardiol Young. 2009 Aug; 19(4):320-30.
Score: 0.010
-
Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study). Am J Cardiol. 2009 Aug 01; 104(3):419-28.
Score: 0.010
-
Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008 Jul 08; 52(2):85-98.
Score: 0.009
-
Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007 Dec; 120(6):e1434-40.
Score: 0.009
-
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007 Jul 10; 116(2):174-9.
Score: 0.008
-
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75.
Score: 0.008
-
Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation. 2006 Feb 28; 113(8):1123-9.
Score: 0.008
-
Early experience with real-time three-dimensional echocardiographic guidance of right ventricular biopsy in children. Echocardiography. 2006 Jan; 23(1):45-9.
Score: 0.008
-
Left atrial decompression by percutaneous cannula placement while on extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2005 Aug; 130(2):595-6.
Score: 0.007
-
Inhaled nitric oxide does not improve systemic oxygenation after bidirectional superior cavopulmonary anastomosis. J Thorac Cardiovasc Surg. 2005 Jan; 129(1):217-9.
Score: 0.007
-
Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium). Am J Cardiol. 2004 Mar 15; 93(6):801-3.
Score: 0.007
-
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003 Feb 25; 107(7):996-1002.
Score: 0.006
-
Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg. 2001 Sep; 122(3):440-8.
Score: 0.006